Literature DB >> 7721551

Cognitive impairment and quality of life in long-term survivors of malignant brain tumors.

A R Giovagnoli1, A Boiardi.   

Abstract

Thirtysix long-term survivors following the treatment of a malignant supratentorial brain tumor were examined for cognitive functions and global level of autonomy. Eighteen patients were symptom-free (SF) and 18 had clinical and neuroradiological recurrence (RE). The control group included 30 healthy subjects. All subjects underwent a neuropsychological battery for general and specific cognitive functions. The level of autonomy was assessed by means of the Karnofsky Performance Scale (KPS) for oncological patients. SF patients showed less impairment than RE patients both at the tests, as well as on the KPS. The cognitive deficits were subclinical in most SF patients, the tests for attention, memory and word fluency being the most sensitive in detecting subtle dysfunctions. The association between tumor location and specific cognitive deficits was inconstant in both patient groups. The results suggest that even subtle cognitive deficits can prevent SF long-term survivors from returning to premorbid autonomy and occupations, and that neuropsychological tests may be used as complementary routine indicators of their quality of life. Furthermore, our data show that, in selected patients, combined treatments and therapeutic insistence do not necessarily have the same deleterious effects.

Entities:  

Mesh:

Year:  1994        PMID: 7721551     DOI: 10.1007/bf02334609

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  23 in total

1.  Raven's coloured progressive matrices: normative values on 305 adult normal controls.

Authors:  A Basso; E Capitani; M Laiacona
Journal:  Funct Neurol       Date:  1987 Apr-Jun

2.  Some problems associated with neuropsychological assessment.

Authors:  A Benton
Journal:  Bull Clin Neurosci       Date:  1985

3.  Long term survival among patients with malignant brain tumors.

Authors:  A N Lieberman; S H Foo; J Ransohoff; A Wise; A George; W Gordon; R Walker
Journal:  Neurosurgery       Date:  1982-04       Impact factor: 4.654

4.  Quality of life in long-term survivors of CNS tumors of childhood and adolescence.

Authors:  E N Mostow; J Byrne; R R Connelly; J J Mulvihill
Journal:  J Clin Oncol       Date:  1991-04       Impact factor: 44.544

5.  Neuropsychologic function in children with brain tumors: III. Interval changes in the six months following treatment.

Authors:  R K Mulhern; L E Kun
Journal:  Med Pediatr Oncol       Date:  1985

6.  Evaluation of patients with advanced cancer using the Karnofsky performance status.

Authors:  J W Yates; B Chalmer; F P McKegney
Journal:  Cancer       Date:  1980-04-15       Impact factor: 6.860

7.  Differential perseverations in verbal retrieval related to anterior and posterior left hemisphere lesions.

Authors:  J Vilkki
Journal:  Brain Lang       Date:  1989-05       Impact factor: 2.381

8.  Quality of life self-reports from 200 brain tumor patients: comparisons with Karnofsky performance scores.

Authors:  N Mackworth; P Fobair; M D Prados
Journal:  J Neurooncol       Date:  1992-11       Impact factor: 4.130

9.  Neuropsychological assessment outcomes of nonacquired immunodeficiency syndrome patients with primary central nervous system lymphoma before and after blood-brain barrier disruption chemotherapy.

Authors:  J R Crossen; D L Goldman; S A Dahlborg; E A Neuwelt
Journal:  Neurosurgery       Date:  1992-01       Impact factor: 4.654

10.  Neuropsychological impairments associated with lesions caused by tumor or stroke.

Authors:  S W Anderson; H Damasio; D Tranel
Journal:  Arch Neurol       Date:  1990-04
View more
  24 in total

1.  Quality of life in patients with stable disease after surgery, radiotherapy, and chemotherapy for malignant brain tumour.

Authors:  A R Giovagnoli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-09       Impact factor: 10.154

Review 2.  Renin-angiotensin system blockers and modulation of radiation-induced brain injury.

Authors:  M E Robbins; W Zhao; M A Garcia-Espinosa; D I Diz
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

3.  Cognitive effects of tumour and surgical treatment in glioma patients.

Authors:  Andrea Talacchi; Barbara Santini; Silvia Savazzi; Massimo Gerosa
Journal:  J Neurooncol       Date:  2010-09-28       Impact factor: 4.130

Review 4.  Awake surgery between art and science. Part I: clinical and operative settings.

Authors:  Andrea Talacchi; Barbara Santini; Francesca Casagrande; Franco Alessandrini; Giada Zoccatelli; Giovanna M Squintani
Journal:  Funct Neurol       Date:  2013 Jul-Sep

5.  The association between cognitive functioning and health-related quality of life in low-grade glioma patients.

Authors:  Florien W Boele; Maaike Zant; Emma C E Heine; Neil K Aaronson; Martin J B Taphoorn; Jaap C Reijneveld; Tjeerd J Postma; Jan J Heimans; Martin Klein
Journal:  Neurooncol Pract       Date:  2014-05-06

Review 6.  The quality of measurement properties of neurocognitive assessment in brain tumor clinical trials over the last 30 years: a COSMIN checklist-based approach.

Authors:  Maria De Martino; Barbara Santini; Giovanna Cappelletti; Annapina Mazzotta; Matteo Rasi; Giorgia Bulgarelli; Luciano Annicchiarico; Alessandro Marcocci; Andrea Talacchi
Journal:  Neurol Sci       Date:  2020-07-12       Impact factor: 3.307

Review 7.  Imaging radiation-induced normal tissue injury.

Authors:  Mike E Robbins; Judy K Brunso-Bechtold; Ann M Peiffer; Christina I Tsien; Janet E Bailey; Lawrence B Marks
Journal:  Radiat Res       Date:  2012-02-21       Impact factor: 2.841

Review 8.  Investigation of cognitive impairments in people with brain tumors.

Authors:  Anna Rita Giovagnoli
Journal:  J Neurooncol       Date:  2012-03-06       Impact factor: 4.130

9.  Facets and determinants of quality of life in patients with recurrent high grade glioma.

Authors:  A R Giovagnoli; A Silvani; E Colombo; A Boiardi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-04       Impact factor: 10.154

Review 10.  Radiation-induced cognitive impairment--from bench to bedside.

Authors:  Dana Greene-Schloesser; Mike E Robbins
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.